The Oncology Association of Bosnia and Herzegovina's recommendations for fertility preservation in oncologic patients.

Autor: Cerić T; Clinic of Oncology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Sokolović E; Clinic of Oncology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Hasanbegović B; Clinic of Oncology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Pašić A; Clinic of Oncology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Gojković Z; Oncology Clinic, Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina., Vladičić Mašić J; University Hospital Foča, Foča, Bosnia and Herzegovina., Dukić N; University Hospital Foča, Foča, Bosnia and Herzegovina., Marijanović I; Oncology Clinic, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina., Mekić Abazović A; Department of Oncology, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina., Šišić I; Department of Oncology, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina., Koprić D; Department of Oncology, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina., Hammami M; Department of Oncology, General hospital 'Dr. Irfan Ljubijankić' Bihać, Bihać, Bosnia and Herzegovina., Bajramović S; Clinic of Urology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Delić T; Polyclinic Sunce, Sarajevo, Bosnia and Herzegovina., Bešlija S; Clinic of Oncology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Jazyk: angličtina
Zdroj: Bosnian journal of basic medical sciences [Bosn J Basic Med Sci] 2022 Sep 16; Vol. 22 (5), pp. 646-650. Date of Electronic Publication: 2022 Sep 16.
DOI: 10.17305/bjbms.2021.6977
Abstrakt: Malignancy is one of the major public health problems in Bosnia and Herzegovina. Along with breakthroughs in specific oncological therapy, improving the quality of life of cancer patients and management of therapy-induced side effects need to be recognized as a priority in the comprehensive cancer patient care. Fertility loss after cancer treatment is a field requiring special attention due to its various consequences on patients themselves.  Although oncofertility is well-recognized area of oncology, low- to middle-income countries are facing issues with its implementation in everyday practice. Increased awareness about fertility preservation is of high priority for all specialists who participate in the medical care of cancer patients. The absence of a systemic solution and lack of expertise led to the founding of Fertility Preservation Working Group of the Oncology Association of Bosnia and Herzegovina. We have made recommendationsas an expert consensus with the ultimate goal of making the first step towards enhancement of oncofertility implementation in Bosnia and Herzegovina.
Databáze: MEDLINE